| 2024-09-02 |
详情>>
拆分方案：
每12.0000合并分成1.0000股
|
| 2024-08-31 |
停牌提示：
2024-08-30 19:50:00 停牌:
停牌原因 ▼▲
- 原因：
- Halt - News Pending_x000D_
Trading is halted pending the release of material news.
|
| 2024-08-29 |
详情>>
股本变动：
变动后总股本120.89万股
变动原因 ▼▲
- 原因：
- every 12 shares of the combined company’s common stock outstanding will be combined and reclassified into 1 share of the combined company’s common stock
|
| 2024-08-01 |
详情>>
业绩披露：
2024年中报每股收益-0.32美元,归母净利润-468.7万美元,同比去年增长-65.85%
|
| 2024-04-25 |
详情>>
业绩披露：
2024年一季报每股收益-0.14美元,归母净利润-200.9万美元,同比去年增长-49.26%
|
| 2024-02-01 |
详情>>
业绩披露：
2023年年报每股收益-0.37美元,归母净利润-533.9万美元,同比去年增长46.21%
|
| 2023-12-19 |
股东大会：
将于2024-01-30召开股东大会
会议内容 ▼▲
- 1.To elect the Board of Directors’ nominees, Dr. Michael R. Bristow and Mr. Robert E. Conway, to the Board of Directors to hold office until the 2026 Annual Meeting of Stockholders;
2.To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2023.
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
4.Any other business that is properly brought before the meeting.
|
| 2023-10-18 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.29美元,归母净利润-425万美元,同比去年增长51.44%
|
| 2023-07-21 |
详情>>
业绩披露：
2023年中报每股收益-0.2美元,归母净利润-282.6万美元,同比去年增长55.97%
|
| 2023-04-24 |
详情>>
业绩披露：
2023年一季报每股收益-0.09美元,归母净利润-134.6万美元,同比去年增长58.86%
|
| 2023-02-24 |
详情>>
业绩披露：
2022年年报每股收益-0.69美元,归母净利润-992.6万美元,同比去年增长48.63%
|
| 2022-11-03 |
股东大会：
将于2022-12-15召开股东大会
会议内容 ▼▲
- 1.To elect the Board of Directors’ nominees, Drs. Linda Grais and Anders Hove and Mr. James Flynn, to the Board of Directors to hold office until the 2025 Annual Meeting of Stockholders;
2.To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2022.
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
4.Any other business that is properly brought before the meeting.
|
| 2022-10-28 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-0.61美元,归母净利润-875.2万美元,同比去年增长35.86%
|
| 2022-08-02 |
详情>>
业绩披露：
2022年中报每股收益-0.45美元,归母净利润-641.9万美元,同比去年增长28.15%
|
| 2022-05-02 |
详情>>
业绩披露：
2022年一季报每股收益-0.23美元,归母净利润-327.2万美元,同比去年增长20.20%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-21 |
股东大会：
将于2021-06-10召开股东大会
会议内容 ▼▲
- 1.To elect the Board of Directors’ nominees, Dr. Raymond Woosley and Mr. Dan Mitchell, to the Board of Directors to hold office until the 2024 Annual Meeting of Stockholders;
2.To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2021.
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
4.Any other business that is properly brought before the meeting.
|
| 2020-12-09 |
股东大会：
将于2020-12-10召开股东大会
会议内容 ▼▲
- 1.To elect the Board of Directors’ nominees, Dr. Michael R. Bristow and Mr. Robert E. Conway, to the Board of Directors to hold office until the 2023 Annual Meeting of Stockholders;
2.To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2020.
3.To approve the 2020 ARCA Equity Incentive Plan.
4.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
5.Any other business that is properly brought before the meeting.
|
| 2019-10-25 |
股东大会：
将于2019-12-10召开股东大会
会议内容 ▼▲
- 1.To elect the Board of Directors’ nominees, Drs. Linda Grais and Anders Hove, to the Board of Directors to hold office until the 2022 Annual Meeting of Stockholders;
2.To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2019.
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
4.To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company’s named executive officers.
5.Any other business that is properly brought before the meeting.
|
| 2019-04-04 |
详情>>
拆分方案：
每18.0000合并分成1.0000股
|
| 2018-09-20 |
股东大会：
将于2018-10-18召开股东大会
会议内容 ▼▲
- 1.To approve amendments to the Company’s restated certificate of incorporation, as amended, and authorize the Company’s Board of Directors, if in their judgment it is necessary, to select and file one such amendment to effect a reverse stock split of our common stock, at a ratio of between 1-for-3 and 1-for-20, inclusive, such ratio to be determined at the discretion of the Board of Directors;
2.Any other business that is properly brought before the meeting.
|
| 2018-04-18 |
股东大会：
将于2018-05-31召开股东大会
会议内容 ▼▲
- 1.To elect the Board of Directors’ nominees, Dr. Raymond L. Woosley and Dan J. Mitchell, to the Board of Directors to hold office until the 2021 Annual Meeting of Stockholders.
2.To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2018.
3.To conduct any other business properly brought before the meeting.
|
| 2017-04-21 |
股东大会：
将于2017-06-01召开股东大会
会议内容 ▼▲
- 1. To elect the Board of Directors’ nominees, Dr. Michael R. Bristow and Robert E. Conway, to the Board of Directors to hold office until the 2020 Annual Meeting of Stockholders.
2. To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2017.
3.To conduct any other business properly brought before the meeting.
|
| 2016-04-27 |
股东大会：
将于2016-06-09召开股东大会
会议内容 ▼▲
- 1. To elect the Board of Directors’ nominee, Dr. Linda Grais, to the Board of Directors to hold office until the 2019 Annual Meeting of Stockholders.
2. To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2016.
3. To approve the Amended and Restated ARCA 2013 Equity Incentive Plan.
4. To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement.
5. To conduct any other business properly brought before the meeting.
|
| 2015-09-03 |
详情>>
拆分方案：
每7.0000合并分成1.0000股
|
| 2015-06-05 |
股东大会：
将于2015-06-22召开股东大会
会议内容 ▼▲
- 1. To elect the Board’s nominees, Dr. Raymond L. Woosley and Mr. Dan J. Mitchell, to the Board of Directors to hold office until the 2018 Annual Meeting of Stockholders.
2. To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2015.
3. To approve amendments to the Company’s restated certificate of incorporation, as amended, and authorize the Board of Directors, if in their judgment it is necessary, to select and file one such amendment to effect a reverse stock split of our common stock, at a ratio in the range of 3:1 to 20:1, such ratio to be determined at the discretion of the Board of Directors.
4. To conduct any other business properly brought before the meeting.
|
| 2015-02-12 |
详情>>
内部人交易：
Selby Brian L.等共交易4笔
|
| 2014-04-15 |
股东大会：
将于2014-06-05召开股东大会
会议内容 ▼▲
- 1. To elect the Board’s nominees, Dr. Michael Bristow and Mr. Robert Conway, to the Board of Directors to hold office until the 2017 Annual Meeting of Stockholders.
2. To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2014.
3. To conduct any other business properly brought before the meeting.
|